Literature DB >> 20078116

Characterization of the intestinal absorption of arsenate, monomethylarsonic acid, and dimethylarsinic acid using the Caco-2 cell line.

Marta Calatayud1, Jose Gimeno, Dinoraz Vélez, Vicenta Devesa, Rosa Montoro.   

Abstract

Many toxicological studies have been conducted with arsenic species in target organ cell lines. However, although epithelial gastrointestinal cells constitute the first barrier to the absorption of contaminants, studies using intestinal cells are scarce. The present study examines absorption through the intestinal epithelium of the pentavalent arsenic species most commonly found in foods [arsenate, As(V); monomethylarsonic acid, MMA(V); and dimethylarsinic acid, DMA(V)], using the Caco-2 cell line as a model. Different concentrations (1.3-667.6 microM) and culture conditions (media, pH, addition of phosphates, and treatment with ethylenediaminetetraacetic acid) were evaluated to characterize such transport. The apparent permeabilities indicate that the methylated species show low absorption, whereas As(V) is a compound with moderate absorption. The kinetic study shows only a saturable component for MMA(V) transport in the range of concentrations assayed. The existence of paracellular transport was shown for all of the species, with greater significance in the case of the methylated forms. As(V) absorption was inhibited by 10 mM phosphate, and a phosphate transporter therefore could take part in intestinal absorption. Acidification of the medium (pH 5.5) resulted in a marked increase in As(V) and DMA(V) permeability (4-8 times, respectively) but not in MMA(V) permeability. This makes it necessary to consider the possible existence of absorption in the proximal intestine and even in the stomach, where the environment is acidic; alternatively, an H(+)-dependent transporter may be involved. The results obtained constitute the basis for future research on the mechanisms involved in the intestinal absorption of arsenic and its species, a decisive step in relation to their toxic action.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20078116     DOI: 10.1021/tx900279e

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  17 in total

1.  Using mathematical modeling to infer the valence state of arsenicals in tissues: A PBPK model for dimethylarsinic acid (DMAV) and dimethylarsinous acid (DMAIII) in mice.

Authors:  Lydia M Bilinsky; David J Thomas; Jeffrey W Fisher
Journal:  J Theor Biol       Date:  2018-10-26       Impact factor: 2.691

Review 2.  Uptake, Metabolic Effects and Toxicity of Arsenate and Arsenite in Astrocytes.

Authors:  Ralf Dringen; Sabrina Spiller; Sarah Neumann; Yvonne Koehler
Journal:  Neurochem Res       Date:  2015-04-11       Impact factor: 3.996

Review 3.  Human exposure to organic arsenic species from seafood.

Authors:  Vivien Taylor; Britton Goodale; Andrea Raab; Tanja Schwerdtle; Ken Reimer; Sean Conklin; Margaret R Karagas; Kevin A Francesconi
Journal:  Sci Total Environ       Date:  2016-12-24       Impact factor: 7.963

4.  Embryonic arsenic exposure reduces intestinal cell proliferation and alters hepatic IGF mRNA expression in killifish (Fundulus heteroclitus).

Authors:  Kaleigh C Sims; Katey L Schwendinger; Dana B Szymkowicz; Jonathan R Swetenberg; Lisa J Bain
Journal:  J Toxicol Environ Health A       Date:  2019-02-07

5.  Oxidative stress, epigenetics, and cancer stem cells in arsenic carcinogenesis and prevention.

Authors:  Lingzhi Li; Fei Chen
Journal:  Curr Pharmacol Rep       Date:  2016-01-23

6.  Characterization of arsenate uptake by cultured primary rat astrocytes.

Authors:  Yvonne Koehler; Ralf Dringen
Journal:  Neurochem Res       Date:  2013-06-01       Impact factor: 3.996

Review 7.  Arsenic Exposure and Compromised Protein Quality Control.

Authors:  Lok Ming Tam; Yinsheng Wang
Journal:  Chem Res Toxicol       Date:  2020-06-02       Impact factor: 3.739

8.  SLCO1B1 variants and urine arsenic metabolites in the Strong Heart Family Study.

Authors:  Matthew O Gribble; Venkata Saroja Voruganti; Cheryl D Cropp; Kevin A Francesconi; Walter Goessler; Jason G Umans; Ellen K Silbergeld; Sandra L Laston; Karin Haack; Wen Hong Linda Kao; Margaret Daniele Fallin; Jean W Maccluer; Shelley A Cole; Ana Navas-Acien
Journal:  Toxicol Sci       Date:  2013-08-22       Impact factor: 4.849

9.  Development and characterization of a new oral dapsone nanoemulsion system: permeability and in silico bioavailability studies.

Authors:  Lidiane M Monteiro; Viviane F Lione; Flavia A do Carmo; Lilian H do Amaral; Julianna H da Silva; Luiz E Nasciutti; Carlos R Rodrigues; Helena C Castro; Valeria P de Sousa; Lucio M Cabral
Journal:  Int J Nanomedicine       Date:  2012-09-28

10.  In vitro intestinal bioavailability of arsenosugar metabolites and presystemic metabolism of thio-dimethylarsinic acid in Caco-2 cells.

Authors:  Larissa Leffers; Christoph A Wehe; Sabine Hüwel; Marc Bartel; Franziska Ebert; Mojtaba S Taleshi; Hans-Joachim Galla; Uwe Karst; Kevin A Francesconi; Tanja Schwerdtle
Journal:  Metallomics       Date:  2013-08       Impact factor: 4.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.